Biblio
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma. Ann Hematol. 2013.
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood Cancer J. 2022;12(12):165.